文献速递间质性肺疾病

界定特发性肺纤维化工作诊断的诊断可能性阈值

Diagnostic Likelihood Thresholds That Define a Working Diagnosis of Idiopathic Pulmonary Fibrosis.
PubMed 文献 · Am J Respir Crit Care Med · 2019-01-01

该国际队列研究让404名呼吸科医生评估60例间质性肺疾病病例,以确定在疑诊特发性肺纤维化(IPF)时,医生在何种诊断可能性水平下不要求外科肺活检(SLB)而直接处方抗纤维化治疗。结果显示,在 provisional high-confidence IPF 诊断(可能性≥70%)时,63.0%的病例未要求SLB即处方抗纤维化治疗,且与明确诊断IPF相比死亡率无显著差异。

要点

  • provisional high-confidence IPF诊断(可能性≥70%)时多数医生直接处方抗纤维化治疗而不要求SLB。
  • 明确IPF诊断与 provisional high-confidence IPF诊断之间死亡率无显著差异(HR 0.97)。
  • 仅在少数疑似但非明确IPF患者中推荐SLB。

核心结论

  • 多数呼吸科医生在可作出 provisional high-confidence IPF诊断或工作诊断(可能性≥70%)时,不要求SLB即处方抗纤维化治疗。
  • 仅在少数疑似但非明确IPF患者中推荐SLB。

研究设计与样本

  • 国际队列研究,404名呼吸科医生评估60例间质性肺疾病病例,共24,240次医生-患者评估。
  • 医生提供鉴别诊断及诊断可能性、SLB决策和初始管理,诊断按Ryerson等提出的可能性分层。

主要发现

  • IPF出现在41.1%(9,958/24,240)的医生-患者评估的鉴别诊断中。
  • 在明确、 provisional high-confidence 和 provisional low-confidence IPF诊断中,要求SLB的比例分别为8.1%、29.6%和48.4%。
  • 在63.0%的 provisional high-confidence IPF诊断中,未要求SLB即处方抗纤维化治疗。
  • 明确IPF诊断(诊断可能性90-100%)与 provisional high-confidence IPF诊断之间死亡率无显著差异(HR 0.97;P=0.65;95%CI 0.90-1.04)。

关键数值与推荐

  • provisional high-confidence IPF诊断对应诊断可能性≥70%。
  • 明确IPF诊断对应诊断可能性90-100%。

临床怎么用

  • 对于疑似IPF患者,若能达到 provisional high-confidence 诊断(可能性≥70%),可考虑不要求SLB而处方抗纤维化治疗。
  • SLB应保留给疑似但非明确IPF的少数患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: The level of diagnostic likelihood at which physicians prescribe antifibrotic therapy without requesting surgical lung biopsy (SLB) in patients suspected of idiopathic pulmonary fibrosis (IPF) is unknown.Objectives: To determine how often physicians advocate SLB in patient subgroups defined by IPF likelihood and risk associated with SLB, and to identify the level of diagnostic likelihood at which physicians prescribe antifibrotic therapy with requesting SLB.Methods: An international cohort of respiratory physicians evaluated 60 cases of interstitial lung disease, giving: 1) differential diagnoses with diagnostic likelihood; 2) a decision on the need for SLB; and 3) initial management. Diagnoses were stratified according to diagnostic likelihood bands described by Ryerson and colleagues.Measurements and Main Results: A total of 404 physicians evaluated the 60 cases (24,240 physician-patient evaluations). IPF was part of the differential diagnosis in 9,958/24,240 (41.1%) of all physician-patient evaluations. SLB was requested in 8.1%, 29.6%, and 48.4% of definite, provisional high-confidence and provisional low-confidence diagnoses of IPF, respectively. In 63.0% of provisional high-confidence IPF diagnoses, antifibrotic therapy was prescribed without requesting SLB. No significant mortality difference was observed between cases given a definite diagnosis of IPF (90-100% diagnostic likelihood) and cases given a provisional high-confidence IPF diagnosis (hazard ratio, 0.97; P = 0.65; 95% confidence interval, 0.90-1.04).Conclusions: Most respiratory physicians prescribe antifibrotic therapy without requesting an SLB if a provisional high-confidence diagnosis or "working diagnosis" of IPF can be made (likelihood ≥ 70%). SLB is recommended in only a minority of patients with suspected, but not definite, IPF.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Walsh SLF, Lederer DJ, Ryerson CJ, et al. Diagnostic Likelihood Thresholds That Define a Working Diagnosis of Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2019. PMID: 31241357. doi:10.1164/rccm.201903-0493OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。